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Menthol act as anticandidal agent and has the potential for therapy of candidiasis. These results can provide insights into the 
mechanism of menthol against C. albicans.
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Introduction: Fluconazole-resistant Candida albicans is one of the biggest problems seen in 
clinical practices. One of the most common ways to resolve this problem is the use of natural 
pure compounds such as menthol. The aims of this study were to investigate the hyphal 
formation and gene expression profiling of fluconazole-resistant C. albicans treated by menthol.
Methods: Colonization of vaginal isolates of C. albicans was recognized and fluconazole-resistant 
yeasts detected by WHONET software. The relative minimum inhibitory concentrations 
(MICs) of menthol were determined by broth microdilution for fluconazole-resistant isolates. 
The potency of menthol to inhibit hyphal formation was exploited using a light microscope. A 
quantitative real-time RT- PCR was used to measure the expression of SAP1 .
Results: Almost 100% of colonized vaginal isolates of C. albicans was found to be fluconazole-
resistant. MIC90 for menthol in fluconazole-resistant isolates was 1.6 to 25 μg/mL. Furthemore, 
all isolates treated with menthol showed a significant reduction in hyphae and number of 
planktonic cells. In the fluconazole-resistance C. albicans cells treated with fluconazole, the 
expression levels of SAP1 increased by 1.53- (2×MIC conc.) and 1.43-fold (1×MIC conc.). 
However, treatment with menthol down regulated the SAP1 expression by 2.02- and 1.85-fold 
at concentrations of 2 × MIC and 1 × MIC, respectively (P ≤ 0.05).
Conclusion: This study suggests that menthol might have potential applications in treatment 
of infections, due to fluconazole-resistance C. albicans. In addition, SAP1 could be probable 
molecular target of menthol in C. albicans.
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Introduction
A common agent for opportunistic fungal infection of 
candidiasis is Candida albicans. In fact, candidiasis is a 
problem of growing clinical importance, particularly in 
individuals with immunologic (e.g., genetic susceptibility, 
cancer, organ transplant and human immunodeficiency 
virus infection) and non immunologic (e.g., pregnancy, 
neonates and childhood, burn, diabetes and nosocomial 
infections) predisposing conditions which contribute to 
enhanced susceptibility to infections (1-3). 
Candida albicans has developed virulence factors 
with specific strategies to allow its successful host 
tissue colonization. Key virulence factors of C. albicans 
expressed or required for pathogenesis are secreted 
aspartyl proteinases (Saps), encoded by a 10-member 
gene family (SAP1 to SAP10) (3-6). These enzymes with 
a signal peptide are secreted into the extracellular space. 
Sap9 and Sap10 are cell wall-associated proteases (7). 
Based on the amino acid sequence alignments and protein 
homology, the 10 SAP genes are classified into three 
subfamilies. The subfamilies consist of the SAP1 to SAP3, 
SAP4 to SAP6, SAP9, and SAP10 genes (SAP7 and SAP8 
are divergent) (5,6,8,9). The proteolytic activity of the Sap 
proteins could be involved in binding to the host cells 
and degradation of various host tissue barriers, immune 
response evasion, facilitate the nutrient availability for 
fungal growth from host protein digestion, adhesion and 
survival of fungal cells within host cells (10,11). Several 
studies have described differential expression of SAP 
family, in vitro and in vivo, during candidiasis (4-6). The 
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expression pattern of these genes in the pathogenesis of C. 
albicans infection are associated with a number of other 
putative virulence factors of C. albicans including hypha 
formation, adhesion and phenotypic switching. Therefore, 
the expression of SAP genes varies at different stages of 
fungal growth and disease (3,5,6). Identification of SAP1 
gene was done by Hube et al (12) and characterization 
of the protein product by White et al (13). Sap1 enzyme 
related to yeast cell form is activiated in an acidic pH 
environment. Expression of SAP1 is strain-specifc and 
it has been shown that Sap1 contribute significantly to 
mucosal infections (5,6,9,14). Sap1 is produced during 
growth in media containing proteins as the sole nitrogen 
source. Furthermore, SAP1 mutants of C. albicans grew 
slowly after induction in proteinase-inducing medium 
and the production of their own proteinases were delayed 
compared with the parental wild type strain. The virulence 
of mutant strains lacking SAP1 gene slightly reduced in 
animal models of candidiasis (14).
The widespread use of antifungal therapy has been 
associated with a marked increase in the incidence of 
treatment failures in candidiasis patients resulting from 
antifungal drug resistance with a serious threat to life 
(15,16). Recently, natural pure  antifungal compounds 
derived from plants, such as menthol, have received a 
great deal of attention. Menthol (C10H20O) is a terpenoid 
compound of the Mentha genus in the Lamiaceae 
family. Results from several studies show that menthol 
possesses an antifungal activity (17-20). Menthol exerts its 
antifungal activity on the cell membrane permeability and 
the cell wall consistency, hence probably causing cell death 
or inhibiting the filamentation of C. albicans (18,21). The 
aim of the prresent study was to evaluate the antifungal 
effect of menthol against fluconazole-resistant C. albicans 
vaginal isolates in pregnant women. In particular, we 
performed antifungal susceptibility, hypha formation 
and gene expression profiling of C. albicans treated with 
menthol. 
Materials and Methods 
Microorganisms
Via vaginal swabs, 30 isolates of C. albicans were obtained 
from 100 healthy pregnant women who admitted in 
Ahvaz Imam Khomeini hospital affiliated to Jundishapur 
University of Medical Sciences, Ahvaz, Iran. Isolates 
were grown in Sabouraud Dextrose Agar (SDA, Biolife, 
Italy) at 37°C for 24 hours and identified by wet mount 
microscopy, Gram stain, macroscopic morphology on 
SDA and CHROMagar™ Candida (CHROMagar, France) 
and germ tube formation in human serum. Quality control 
strains of C. albicans ATCC 14053 and fluconazole-
resistant C. albicans ATCC MYA-573 were also employed. 
Stock cultures of C. albicans were maintained at -75°C in 
Sabouraud Dextrose Broth (SDB, Biolife) containing 20% 
sterile glycerol. Before conducting the assays, each isolate 
was subcultured two or more times on SDA. Selected 
colonies (1 mm in dimater) were transferred to the sterile 
0.85% NaCl. An optical density at 530 nm (OD530) for 
each isolate was adjusted to 0.08-0.10 using 0.85% NaCl 
sterile to give a standard inoculum of 1-5 ×106 CFU/mL 
(22). 
Antifungal susceptibility of fluconazole
The disk diffusion (CLSI M44-A2) and broth microdilution 
(CLSI M27-A3 and CLSI M27-S4) methods were used 
to test antifungal susceptibility of fluconazole against C. 
albicans. Results of susceptibility of isolates to fluconazole 
were analyzed using WHONET software (23). 
Antifungal susceptibility of menthol
The susceptibility of menthol (M2772 Sigma-Aldrich Co. 
St. Louis, MO, USA) was measured according to the CLSI 
antifungal susceptibility method for yeasts (CLSI  M27-A3 
and CLSI M27-S4). After dissolving menthol in DMSO, 
one hundred μL of the two-fold dilution of menthol (range 
0.0313–50 μg/mL) were prepared into 96-well plates in 
RPMI 1640 with L-glutamine and without bicarbonate 
(Sigma-Aldrich) supplemented with 2% glucose and 
MOPS buffer. C. albicans inoculum (0.5–5 × 103 CFU/mL) 
was then inoculated into 96-well plates and incubated 
for 24 hours at 35°C. Growth (menthol-free) and sterility 
(medium alone) control wells were established on each 
test plate. 
Relative MICs were measured at OD530 using a Stat 
Fax 303 Reader (Awareness Technology, Inc., USA). The 
lowest concentration in which ≥50% or 90% reduction 
of growth was evident considered to be a relative MIC. 
Fluconazole was used as a control (22,23).
Candida albicans hypha formation 
Candida albicans ATCC MYA-573 was induced to form 
hypha formation according to the method described by 
Khodavandi et al (24). For hypha formation, 4 mL of 
menthol and fluconazole at 2× MIC and 1× MIC were 
prepared in 6-cm Petri dishes and 4 mL of C. albicans 
inoculum (1-5 ×106 CFU/mL) was added on the Petri 
dishes. The dishes were incubated at 35°C for 90 minutes 
and the mixture was then incubated at 35°C for 16 hours 
with gentle shaking. The hyphae were briefly washed in 
PBS and observed with a light microscope (Leica, DMRA 
II, Germany). 
Expression of Candida albicans SAP1
The expression assay of SAP1 gene was conducted using 
relative quantitative Real time PCR (qRT-PCR) that 
was adapted from a previously described method (23). 
C. albicans ATCC MYA-573 treated with menthol and 
fluconazole was induced to form hypha formation. Total 
RNA was extracted using a RNeasy Mini Kit (Qiagen, 
Hilden, Germany) containing DNase I in accordance 
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with manufacturer’s instructions. RNA quality and 
quantity were determined by spectrophotometric in a 
NanoDrop® ND1000- spectrophotometer (NanoDrop 
Technologies Inc., Wilmington, DE) and electrophoresis 
on a formaldehyde-denaturing agarose gel. The first 
strand of cDNA was synthesized using M-MuLV 
reverse transcriptase (Fermentas, USA) according to 
the manufacturer’s instructions, using random hexamer 
oligonucleotides and total RNA (0.5 μg). The qRT-PCR 
was performed using SYBR™ Green qPCR Master Mix 
(Fermentas, EU) on a Bio-Rad MiniOpticonTM system 
(USA). The oligonucleotide primers used for qRT‐PCR 
were listed in Table 1. The expression levels of SAP1 
gene were calculated by comparative Ct method (2−∆Ct 
formula) after normalization with beta actin gene (23,25). 
Statistical analysis
All experiments were performed in duplicate or triplicate. 
Differences between specific means were analyzed by 
a one-way analysis of variance (ANOVA). Results are 
shown as the mean value ± standard deviation (SD). 
Values of P < 0.05 were considered to be significant. The 
SPSS software (version 21; SPSS Inc., Chicago, IL) was 
used for statistical analysis. 
Results
Clinical isolates of C. albicans were identified by 
morphological and biochemical characterization. Of 100 
healthy women at the end of the pregnancy, 30 C. albicans 
were isolated and identified. The antifungal susceptibility 
of fluconazole on the growth of clinical isolates of C. 
albicans (using disk diffusion and broth microdilution 
methods) is reported in Table 2. Out of clinical isolates of 
C. albicans, 100% were found to be fluconazole-resistant. 
Kappa coefficient showed that there was a high degree 
of agreement between disk inhibition zone diameter and 
MICs for fluconazole. 
The broth microdilution results obtained for the 
menthol compared with fluconazole against clinical 
isolates of C. albicans are reported in Table 3. Menthol 
induced a significant growth inhibition compared with 
fluconazole for C. albicans. The results showed a MIC90 
of 1.6-25 µg/mL for fluconazole-resistance isolates of C. 
albicans.
Findings from potency of menthol to inhibit hypha 
formation of the C. albicans ATCC MYA-573 exhibited 
a significant reduction in hyphae and planktonic cells 
compared to the untreated control. Figure 1 shows the 
inhibitory property of menthol on C. albicans ATCC 
MYA-573 hyphal formation at concentrations of 2× MIC 
and 1× MIC after 16 hours. The effect of fluconazole 
was not dramatically decreased hyphae and planktonic 
cells of fluconazole-resistant C. albicans compared to the 
untreated control.
QRT-PCR was performed to investigate the effect of 
menthol on the expression of SAP1 gene in fluconazole-
resistance C. albicans cells (ATCC MYA-573). Box plots 
are shown in Figure 2. Fluconazole-resistance C. albicans 
cells showed significant changes in the expression levels 
of SAP1 compared to the untreated control (P ≤ 0.05). 
Treatment with fluconazole increased expression of SAP1 
by 1.53- and 1.43-fold at concentrations of 2 × MIC and 
1 × MIC, respectively. In the fluconazole-resistance C. 
albicans cells treated with menthol the expression levels 
of SAP1 were down regulated by 2.02- and 1.85-fold at 
concentrations of 2 × MIC and 1 × MIC, respectively (P 
≤ 0.05).
Discussion
Fluconazole resistance has been identified as the 
main cause of treatment failure of candidiasis (27,28). 
Considering a major clinical challenge of antifungal 
resistance, the antimicrobial potential of the natural 
products can be regarded as a precious resource. In this 
study, we showed that menthol displays a potential anti-
Candida activity. The antifungal activities of menthol are 
Table 1. Oligonucleotide primer sequences  used for qRT‐PCR
Primer Orientation Sequence Reference
SAP1 Forward 5' TTTCATCGCTCTTGCTATTGCTT 3′ (6)
Reverse 5′ TGACATCAAAGTCTAAAGTGACAAAACC 3′ 
ACT Forward 5' GAGTTGCTCCAGAAGAACATCCAG 3' (26)
Reverse 5' TGAGTAACACCATCACCAGAATCC 3' 
Table 2. Results susceptibility of fluconazole using disk diffusion and broth microdilution methods against Candida albicans vaginal 
isolates in pregnant women
Susceptibility 
method
Antibiotic 
name N %R %I %S %R 95% CI
Geom. 
Mean
MIC range
µg/mL
Disk zone diameter (mm) 
distribution
MIC90 (μg/mL) 
distribution
9 10 11 12 16 32 64
Disk diffusion Fluconazole 30 100 0 0 85.9‐100 ‐ ‐ 33.3% 20% 43.3% 3.3% ‐ ‐ ‐
Broth microdilution Fluconazole 30 100 0 0 85.9‐100 27.857 8‐64 ‐ ‐ ‐ ‐ 40% 40% 20%
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reported in research studies and within the context of 
existing literature (17-20).
The results presented in this paper showed 100% of 
resistancy in C. albicans vaginal isolates to fluconazole. 
These results are corroborated by the literature, citing 
fluconazole-resistant C. albicans (27-29). Fluconazole 
is a fungistatic rather than fungicidal medication and 
hence provides the opportunity for acquired resistance 
in certain fungi (29). Our data support the effects of 
menthol in fluconazole-resistant C. albicans vaginal 
isolates. Several lines of evidence demonstrate that natural 
pure compounds derived from plants are the most potent 
products to kill antifungal resistant C. albicans (23,30). 
Our results showed that the antifungal activity of 
menthol on the fluconazole-resistant C. albicans is able 
to inhibit hyphal formation with a decreasing in the 
ability of C. albicans cells to adhere to host cell surfaces. 
Following hyphal formation, C. albicans hyphae secreted 
of hydrolases are thought to enhance the efficiency of 
nutrient uptake. In fact, Saps degrades host proteins, 
penetrates into the surrounding tissues and finally evades 
host immune defenses (31). However, the SAP genes play 
key roles in virulence of C. albicans required for infections 
(3-6). In the present study, the relative gene expression 
analyses were performed to investigate the possible effects 
of menthol at molecular level. The main changes in the 
gene expression induced by treatments with menthol were 
down regulated SAP1. These results are in agreement with 
those reported in the literature regarding the effects of 
antifungal agents on the expression of SAP1 (24,30,32). 
Samaranayake et al. (33) indicated that the expression 
levels of SAP1, SAP4, SAP6, SAP8–SAP10 genes were 
significantly higher in the C. albicans SC5314 biofilms 
than in the controls.
Table 3. Relative MIC (μg/mL) values of menthol against Candida albicans vaginal isolates in pregnant women
Isolates / Antifungals
Menthol Fluconazole
MIC90  MIC50 MIC90  MIC50
C. albicans  ATCC 14053 6.50±0.04 1.60±0.02 4.00±0.08 1.00±0.06
C. albicans  ATCC MYA‐573 3.10±0.01 0.80±0.02 64.00±0.70 16.00±0.08
CI‐ 1 12.50±0.20 3.10±0.02 16.00±0.10 2.00±0.02
CI‐ 2 25.00±0.15 3.10±0.02 32.00±0.10 5.00±0.01
CI‐ 3 12.50±0.03 1.60±0.02 64.00±0.01 16.00±0.10
CI‐ 4 12.50±0.01 1.60±0.02 64.00±0.03 5.00±0.02
CI‐ 5 12.50±0.05 3.10±0.01 64.00±0.02 16.00±0.08
CI‐ 6 3.10±0.01 1.60±0.04 16.00±0.03 8.00±0.03
CI‐ 7 3.10±0.04 1.60±0.01 32.00±0.10 4.00±0.03
CI‐ 8 3.10±0.04 0.80±0.02 16.00±0.02 2.00±0.02
CI‐ 9 3.10±0.01 0.80±0.01 32.00±0.05 2.00±0.01
CI‐ 10 12.50±0.04 3.10±0.02 32.00±0.10 5.00±0.02
CI‐ 11 12.50±0.04 6.50±0.02 16.00±0.10 8.00±0.09
CI‐ 12 12.50±0.02 3.10±0.05 32.00±0.50 2.00±0.06
CI‐13 3.10±0.04 0.80±0.02 16.00±0.40 2.00±0.05
CI‐ 14 1.60±0.01 0.80±0.02 32.00±0.30 2.00±0.01
CI‐ 15 12.50±0.05 1.60±0.04 64.00±0.50 10.00±0.10
CI‐ 16 12.50±0.01 1.60±0.02 32.00±0.20 5.00±0.06
CI‐ 17 25.00±0.01 6.50±0.02 16.00±0.05 4.00±0.05
CI‐ 18 12.50±0.01 3.10±0.02 64.00±0.04 2.00±0.03
CI‐ 19 6.50±0.01 3.10±0.05 16.00±0.03 1.00±0.07
CI‐ 20 25.00±0.02 12.50±0.02 32.00±0.10 2.00±0.06
CI‐ 21 12.50±0.04 3.10±0.04 16.00±0.09 1.00±0.02
CI‐ 22 12.50±0.04 1.60±0.04 16.00±0.30 4.00±0.02
CI‐ 23 6.50±0.02 1.60±0.01 32.00±0.10 4.00±0.02
CI‐ 24 3.10±0.04 0.80±0.02 16.00±0.06 1.00±0.04
CI‐25 3.10±0.01 0.40±0.02 16.00±0.40 5.00±0.06
CI‐ 26 12.50±0.04 0.80±0.02 32.00±0.20 4.00±0.06
CI‐ 27 12.50±0.01 1.60±0.02 32.00±0.15 2.00±0.05
CI‐ 28 12.50±0.01 6.50±0.05 64.00±0.08 10.00±0.09
CI‐29 25.00±0.04 3.10±0.04 32.00±0.05 2.00±0.06
CI‐ 30 12.50±0.02 1.60±0.02 16.00±0.06 2.00±0.04
CI: C. albicans vaginal isolates in pregnant women.
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In conclusion, our study demonstrated the efficacy of 
menthol on inhibition of growth, reduction of hyphal 
formation and down regulation SAP1 against fluconazole-
resistance C. albicans. As fluconazole-resistance C. albicans 
is one of the most alarming health issues, this study 
suggests that menthol may have potential applications in 
the treatment of infections due to these resistant fungi. 
In spite of our certainty that the best results are obtained 
by menthol, further investigation may be focused on the 
menthol’s effcets on other significant genes contributing 
to the cell pathogenesis of C. albicans.
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Figure 1. Effect of menthol and fluconazole at concentrations of 
2× MIC and 1× MIC on Candida albicans ATCC MYA-573 hypha 
formation under light microscope at 40x magnification, Bar = 50 
µm. Figure 2. Box plots of SAP1/ACT  ratio at different concentrations 
of menthol and fluconazole based on MIC in Candida albicans 
ATCC MYA-573.
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